FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT

Rhea-AI Summary

FOXO Technologies Inc. (FOXO) announced it will report its financial results for the third quarter of 2022 on November 14, 2022, after market close. A conference call will be held at 3:15 p.m. Central time on the same day to discuss the results and recent business highlights. FOXO is focused on leveraging epigenetic technology to modernize the life insurance industry, utilizing AI to analyze DNA methylation for health biomarkers, enhancing the underwriting process, and improving consumer value prop through its FOXO Longevity Report.

Positive

• Announcement of third quarter financial results on November 14, 2022, indicating transparency and ongoing business operations.
• Focus on epigenetic technology positioned to innovate the life insurance industry, potentially attracting investors.

Negative

• None.

MINNEAPOLIS--(BUSINESS WIRE)-- FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that it will report financial results for the third quarter ended September 30, 2022 after market closes on Monday, November 14, 2022.

Management will host a conference call to discuss third quarter results and recent business highlights at 3:15 p.m. Central time on Monday, November 14, 2022.

The call can be accessed via webcast on the investors section of the Company’s website at www.foxotechnologies.com/investors or by dialing (888) 770-7136 and referencing conference ID 4335886. Participants are encouraged to call in 10 to 15 minutes prior to the scheduled start time.

The webcast will be made available for replay on the Company’s website beginning approximately two hours after the event.

About FOXO Technologies Inc. (“FOXO”)

FOXO is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. FOXO seeks to modernize the life insurance industry by simplifying the consumer underwriting journey with saliva-based biomarkers and enhancing life insurance’s consumer value proposition with the FOXO Longevity Report. For more information about FOXO, visit www.foxotechnologies.com. For more information about FOXO Life, visit www.foxolife.com. For investor information and updates, visit https://foxotechnologies.com/investors/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221104005530/en/

Investor Relations

Cody Slach, Matthew Hausch

Gateway Investor Relations

(949) 574-3860

FOXO@gatewayir.com

Source: FOXO Technologies Inc.

FAQ

When will FOXO report its third quarter financial results?

FOXO will report its financial results for the third quarter on November 14, 2022, after market close.

What time is the FOXO conference call scheduled?

The conference call to discuss third quarter results is scheduled for 3:15 p.m. Central time on November 14, 2022.

How can I access the FOXO conference call?

You can access the FOXO conference call via webcast on their investors' section of the website or by dialing (888) 770-7136 with conference ID 4335886.

What is FOXO Technologies focused on?

FOXO Technologies focuses on commercializing longevity science through epigenetic technology aimed at the life insurance industry.